# Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

> **NCT07111078** · PHASE1 · RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 56 (estimated)

## Conditions studied

- Influenza Prevention
- Pandemic Influenza Prevention

## Interventions

- **BIOLOGICAL:** VRC-FLUMOS0122-00-VP
- **OTHER:** ALFQ

## Key facts

- **NCT ID:** NCT07111078
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-27
- **Primary completion:** 2027-08-18
- **Final completion:** 2027-08-18
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07111078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07111078, "Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT07111078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*